NCT07750821 Balance Training Following Pulmonary Rehabilitation on Balance in People With Chronic Obstructive Pulmonary Disease (COPD)
| NCT ID | NCT07750821 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samantha Harrison |
| Condition | COPD (Chronic Obstructive Pulmonary Disease) |
| Study Type | INTERVENTIONAL |
| Enrollment | 77 participants |
| Start Date | 2026-01-27 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 77 participants in total. It began in 2026-01-27 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to see if a co-designed balance training programme called Sport4Steadiness (S4S), is acceptable to people with COPD and if the study procedures, including recruitment and the collection of outcomes, is feasible.
Eligibility Criteria
Inclusion Criteria: 1. Adults with spirometry confirmed diagnosis of COPD as per GOLD guidelines (FEV1/FVC ratio below 0.7) or physician confirmed COPD diagnosis 2. Answers yes to one or more of the Three Key Questions\* or Timed up and Go Test result \> 11 seconds 3. An ability and capacity to provide consent to the trial * Q1. Have you fallen in the past year? Q2. Do you feel unsteady when standing or walking? Q3. Do you have worries about falling? Exclusion Criteria: 1. Any neurological, musculoskeletal, chronic pain or other diagnoses that, in the opinion of the investigator, would interfere with the ability of the participant to safely complete PR and balance training 2. Unable to comprehend instruction given verbally in English language 3. Where there is concern that the primary cause of balance issues could be due to problems with visual function, vestibular disturbance or peripheral neuropathy 4. Diagnosis of, or patient-reported symptoms of, vasovagal syncope
Contact & Investigator
Samantha Harrison, Professor
PRINCIPAL INVESTIGATOR
Teesside University
Frequently Asked Questions
Who can join the NCT07750821 clinical trial?
This trial is open to participants of all sexes, studying COPD (Chronic Obstructive Pulmonary Disease). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07750821 currently recruiting?
Yes, NCT07750821 is actively recruiting participants. Contact the research team at s.l.harrison@tees.ac.uk for enrollment information.
Where is the NCT07750821 trial being conducted?
This trial is being conducted at Middlesbrough, United Kingdom, Northallerton, United Kingdom, Stockton-on-Tees, United Kingdom.
Who is sponsoring the NCT07750821 clinical trial?
NCT07750821 is sponsored by Samantha Harrison. The principal investigator is Samantha Harrison, Professor at Teesside University. The trial plans to enroll 77 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.